You are here

Japan biotech venture PeptiDream a US$3b business

Tuesday, June 21, 2016 - 05:50
BT_20160621_CPSUGA21_2344378.jpg
Mr Kubota (right) and Prof Suga, whose lab developed an artificial ribozyme, which he named flexizyme for its "promiscuous" ability to help amino acids couple to form peptides.

Tokyo

WHEN he realised he wasn't going to make it as a guitarist, Hiroaki Suga set out to find the origin of life, and ended up creating a new way to develop medicines.

Many years spent fiddling with the building blocks of the universe - combining molecules to form compounds - led

Powered by GET.comGetCom